Stem cell therapies in the clinic

被引：0
|
作者：
Acharya, Shrinivas [1 ,2 ]
Shaha, Suyog [1 ,2 ]
Bibbey, Michael Griffith [1 ,2 ]
Mukherji, Malini [1 ,2 ]
Zhao, Zongmin [3 ]
Mitragotri, Samir [1 ,2 ]
机构：
[1] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Allston, MA 02138 USA
[2] Harvard Univ, Wyss Inst Biolog Inspired Engn, Boston, MA 02115 USA
[3] Univ Illinois, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL 60607 USA
来源：
BIOENGINEERING & TRANSLATIONAL MEDICINE | 2025年
基金：
美国国家卫生研究院; 美国国家科学基金会;
关键词：
cell; cell therapy; clinical translation; clinical trials; HSC; iPSC; MSC; stem cell; PROOF-OF-CONCEPT; BONE-MARROW; STROMAL CELLS; DIABETES-MELLITUS; TRANSPLANTATION; EFFICACY; PROGRESS; SAFETY; DONOR; OSTEOARTHRITIS;
D O I：
10.1002/btm2.70000
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Stem cell therapies have emerged as a transformative approach in modern medicine, with the potential to address and possibly cure a broad spectrum of diseases. These therapies utilize living stem cells that can perform complex biological functions not replicable by traditional drugs. Stem cell therapies have an expanding therapeutic landscape, with several products already approved and numerous clinical trials underway. Among the various stem cell types, hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are most widely studied. In this review, we provide a detailed analysis of the current clinical landscape of stem cell therapies. We review 27 stem cell products that have received regulatory approvals and discuss 800 ongoing clinical trials, with a focus on HSCs and MSCs. We also discuss the critical challenges to be addressed to facilitate the clinical translation of stem cell therapies.
引用
收藏
页数：25
相关论文
共 50 条
  • [1] Translating stem cell therapies to the clinic
    Miller, Robert H.
    Bai, Lianhua
    NEUROSCIENCE LETTERS, 2012, 519 (02) : 87 - 92
  • [2] Moving breast cancer stem cell therapies to the clinic
    Wicha, M. S.
    CANCER RESEARCH, 2013, 73
  • [3] Integration and translational: driving stem cell therapies toward the clinic
    Trounson, Alan
    REGENERATIVE MEDICINE, 2008, 3 (03) : 269 - 273
  • [4] Pluripotent stem cell-based therapies and their path to the clinic
    Takayama, Kazuo
    Yamanaka, Shinya
    STEM CELL REPORTS, 2023, 18 (08): : 1547 - 1548
  • [5] Prospects for pluripotent stem cell therapies: Into the clinic and back to the bench
    Grabel, Laura
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (02) : 381 - 387
  • [6] The Alpha Stem Cell Clinic: A Model for Evaluating and Delivering Stem Cell-Based Therapies
    Trounson, Alan
    DeWitt, Natalie D.
    Feigal, Ellen G.
    STEM CELLS TRANSLATIONAL MEDICINE, 2012, 1 (01) : 9 - 14
  • [7] Cell therapies in the clinic
    Wang, Lily Li-Wen
    Janes, Morgan E.
    Kumbhojkar, Ninad
    Kapate, Neha
    Clegg, John R.
    Prakash, Supriya
    Heavey, Mairead K.
    Zhao, Zongmin
    Anselmo, Aaron C.
    Mitragotri, Samir
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2021, 6 (02)
  • [8] STEM CELLS CIRM Awards Seek to Move Cell Therapies to the Clinic
    Kaiser, Jocelyn
    SCIENCE, 2009, 326 (5954) : 780 - 781
  • [9] The advancement of human pluripotent stem cell-derived therapies into the clinic
    Thies, R. Scott
    Murry, Charles E.
    DEVELOPMENT, 2015, 142 (18): : 3077 - 3084
  • [10] From basic research to the clinic. Obstacles and options for stem cell therapies
    Hescheler, J.
    Hauskeller, C.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2008, 51 (09) : 1014 - 1020
12345